OptiBiotix Health PLC
LSE:OPTI
OptiBiotix Health PLC
Cost of Revenue
OptiBiotix Health PLC
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
OptiBiotix Health PLC
LSE:OPTI
|
Cost of Revenue
-£349.3k
|
CAGR 3-Years
24%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cost of Revenue
-£1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is OptiBiotix Health PLC's Cost of Revenue?
Cost of Revenue
-349.3k
GBP
Based on the financial report for Jun 30, 2023, OptiBiotix Health PLC's Cost of Revenue amounts to -349.3k GBP.
What is OptiBiotix Health PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-35%
Over the last year, the Cost of Revenue growth was 56%. The average annual Cost of Revenue growth rates for OptiBiotix Health PLC have been 24% over the past three years , -35% over the past five years .